Aurinia Pharmaceuticals Inc. (AUPH) vs Celldex Therapeutics, Inc. (CLDX)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AUPH vs CLDX

growth of $100 · dividends reinvested · last 10y
AUPH +288.1% (+14.5%/yr)CLDX -49.1% (-6.5%/yr)AUPH compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$388$51
AUPH CLDX

AUPH vs CLDX: by the numbers

  • •CLDX is the larger company ($2.09B vs $1.99B market cap).
  • •AUPH is profitable (100.84% net margin) while CLDX runs a net loss (-268385.71%).
  • •AUPH grew revenue faster over the past five years (40.17% vs -58.05% CAGR).

Metrics side by side

Valuation

MetricAUPHCLDX
P/E ratio6.77N/A
Forward P/E16.43N/A
P/S ratio6.4018645.62
P/B ratio3.242.92
EV / EBITDA11.02N/A
FCF yield8.70%N/A

Profitability

MetricAUPHCLDX
Gross margin90.36%100.00%
Operating margin37.06%-19160.00%
Net margin100.84%-268385.71%
ROE51.09%-42.07%
ROIC21.77%-45.19%

Growth (annualized)

MetricAUPHCLDX
Revenue CAGR (5Y)40.17%-58.05%
Total return CAGR (5Y)-5.88%-10.28%

Frequently asked

Which has grown faster, AUPH or CLDX?
Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus CLDX at -58.05%.
Is AUPH or CLDX more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus CLDX at -268385.71%.
How have AUPH and CLDX total returns compared?
Over the past 10 years, AUPH delivered 14.53% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.